| Table 4. Mean ± SD of the diameter (μ) of primordial, primary, secondary, antral, atretic follicles and corpus luteum of rats in different groups | ||||||
| Groups | Parameter | |||||
| Primordial | Primary | Secondary | Antral | Atretic | Corpus luteum | |
| Group A | 32.2±0.4 | 42.1±0.5 | 209.1±2.1 | 1087.2±1.6a | 921.0±1.1 | 995.3±0.9a |
| Group B | 25.5±1.7 | 36.9±0.9 | 171±2.1 | 623.1±1.9a | 897.1±1.5 | 557.9±1.5a |
| Group C | 28.7±2.2 | 40.7±0.9 | 175±1.8 | 981.2±1.4 | 906.5±1.3 | 898±0.7 |
| Group D | 30.6±0.5 | 43.1±2.2 | 199±0.4 | 998.0±0.9 | 935.5±0.8 | 1025.4±1.1 |
| Group E | 27.9±0.9 | 37.1±0.7 | 201±0.9 | 995.9±1.2 | 911.0±1.7 | 1001.2±0.7 |
| Same superscript in each column indicate
significant differences at p<0.05. Group (A) which served as the control group and received a daily oral gavage normal saline Group (B) diabetic rats, which received streptozotocin. Group (C) diabetic rats were administered P. atlantica extract (200 mg/kg) daily by gavage. Group (D) non-diabetic rats received similar doses of P. atlantica extract alone. Group (E) diabetic rats were administered glibenclamide (200 mg/kg) daily by gavage. | ||||||